Magazine
Sign up for your free subscription and keep up-to-date.
Upcoming Events
Newsletters
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
Profiles
|
April 18 2007
Developing innovative, safe and effective therapies By Tonya Costoff
Is What Keeps This Executive Focused Heading up a biopharmaceutical company is no easy task, it's full of challenges, risks and plenty of bumps along the way, but Hans J. Mäder, president and CEO of Ambrilia Biopharma Inc., wouldn't have it any other way. |
|
March 12 2007
Biotec A Risky Business But Well Worth It You've heard it before - biotech is a risky business to get into. It costs a lot of money, it's a long process getting a drug to the marketplace and there's never a guarantee at the end of it all that you'll make a profit.
|
|
January 10 2007
Getting To The Point Of Success Through Passion And Patience By Tonya Costoff Passion and patience is what got Dr. T. Nathan Yoganathan where he is today. And just where that is, is the president and chief scientific officer of Med BioGene (MBI), a biotechnology company that is revolutionizing the diagnosis and treatment of certain cancers and cardiovascular disease by identifying the genes known as 'biomarkers', that indicate the presence of such diseases.
|
|
November 27 2006
Ottawa council unveils Canada's top 10 finalists Winning a national award: gratifying. Being able to present that winning concept to an audience of venture capitalists and potential strategic partners: priceless.
|
|
November 27 2006
The Toronto Biotechnology Initiative names new executive director The Toronto Biotechnology Initiative (TBI) announces the appointment of a new executive director, Bill Laidlaw.
|
|
November 27 2006
Canadian biotech among fastest sectors Thirteen Canadian biotechnology companies were among the Deloitte Fast 500, an annual award program ranking the fastest growing technology, media and telecommunications companies based on five year average revenue growth (2001-2005).
|
|
November 07 2006
RBC names new VP Joe Olivier has been appointed Vice-President, Commercial Financial Services for Knowledge Based Industries, Ontario, for RBC Royal Bank.
|
|
November 02 2006
Sunnybrook Expands Emergency And Trauma Centre Sunnybrook Health Sciences Centre broke ground in September on an expanded emergency department (ED) and regional trauma centre.
|
|
November 02 2006
Sanofi Expansion For Single Shot Children alarmed by the sight of a needle might not appreciate the significance just yet, but Sanofi Pasteur announced in September a $30 million capital expansion project to its manufacturing site in Toronto, where it produces combination vaccines that require only one needle.
|
|
November 01 2006
New name in genomics As of October, ChondroGene Ltd. has changed its name to GeneNews Ltd.
|
|
October 24 2006
Young biotech entrepreneur honoured The founder of a successful Prince Edward Island firm producing bioactive animal feed has been among the recipients of an award celebrating his success.
|
|
October 03 2006
Westin To Head Medicure Clinical Development Jan-Ake Westin has been appointed vice-president of Clinical Development for Medicure Inc.
|
|
October 02 2006
Sanofi pasteur to expand Toronto production of new vaccine technology Toronto Region Research Alliance (TRAA) has applauded the decision by Sanofi Pasteur to expand its Connaught Campus to increase its manufacturing capacity of vaccines. The vaccine company currently supplies combination vaccines requiring only one needle to 52 countries around the world.
|
|
September 13 2006
SFU Grad Awarded Top Doctoral Prize Yonghong Bing, PhD, a 2005 doctoral graduate at Simon Fraser University is the recipient of a 2006 Natural Sciences and Engineering Research Council of Canada Doctoral Prize.
|
|
September 11 2006
The Transition Year Transition Therapeutics Inc. isn't a company that sits back and lets things happen. This Toronto-based biopharmaceutical firm is all about action.
|
|
September 08 2006
Eisenhauer Wins Presidency Dr. Elizabeth Eisenhauer, an internationally recognized oncologist, has been appointed president of the National Cancer Institute of Canada.
|
|
August 29 2006
Monsanto Canada Appoints VP, GM Winnipeg-based Monsanto Canada has appointed Sean Gardner as its new vice-president and general manager of Canadian business operations.
|
|
August 10 2006
Northern Exposure Urigen Holdings relocates from California to Vancouver to pursue treatments for urological indications |
|
August 09 2006
Gene Hunter Bags Top National Award Dr. Robert Hegele, known as London, Ont.s gene hunter, recently received the Genetics Society of Canadas top national award.
|
|
August 02 2006
Pheromone Sciences Establishes Business Advisory Board Kelowna, B.C. based Pheromone Sciences Corp. has established a business advisory board to guide the commercialization process for the companys diabetes product.
|
|
July 05 2006
Canadian Chair in Hypertension Appointed Dr. Norm Campbell will serve as the first Canadian Chair in Hypertension Prevention and Control.
|
|
July 05 2006
Thermo Appoints Canadian GM Thermo Electron Corp. (Waltham, MA) has appointed Murray Wigmore as the general manager for the Scientific Instruments division in Canada.
|
|
July 05 2006
AnorMED CEO and President Steps Down With an eye to the future, Michael Abrams, PhD has resigned as president and CEO of AnorMED Inc. (Vancouver, BC) posts he has held since founding the company in 1996.
|
|
May 31 2006
Nobel Laureate Joins UBC UBC is benefiting from the experience and know-how of Nobel Laureate and recent addition to its staff, Carl E. Wieman, PhD.
|
|
May 31 2006
UBC Pioneer Wins Herzberg Medal David Dolphin, PhD, creator of one of the world's most successful eye disease treatments, has been honoured with the 2005 Gerhard Herzberg Canada Gold Medal for Science and Engineering.
|
|
March 13 2006
Janzen Appointed Cardiome President Doug Janzen has been named president and chief business officer of Vancouver-based Cardiome Pharma Corp.
|
|
March 02 2006
Ministry of Research and Innovation Names New DM Ontario Premier Dalton McGuinty has announced the appointment of Alastair Glass, PhD as deputy minister of the provinces Ministry of Research and Innovation.
|
|
March 02 2006
AEterna Regains Cetrorelix Rights, Appoints Board Member AEterna Zentaris Inc. (Quebec City, QC) has regained exclusive worldwide rights (excluding Japan) to cetrorelix, the company's luteinizing hormone releasing hormone (LHRH) antagonist product candidate, through a deal signed with Solvay Pharmaceuticals (Brussels, Belgium).
|
|
March 02 2006
Millenium Appoints Board Chairman Kingston, Ont.-based Millenium Biologix Corp. has appointed Brian S.G. Fielding as executive deputy chairman of its board of directors.
|
|
February 27 2006
AnorMED CEO Wins SCI Award Michael Abrams, PhD, president and CEO of Vancouver-based AnorMED Inc., been awarded the 2006 Julia Levy Award, presented by SCI Canada (London, UK).
|
|
February 06 2006
Cresswell, Stiller Named to Vasogen Board Mississauga, Ont.-based Vasogen Inc. has named Ronald Cresswell, PhD and Dr. Calvin Stiller to its board of directors.
|
|
February 06 2006
Chronogen Appoints New R&D VP Jean-Marie Houle, PhD has been named vice-president of research and development with Montreal-based biopharmaceutical company Chronogen Inc.
|
|
October 25 2005
Response Biomedical Expands RAMP Portfolio Response Biomedical Corp. (Burnaby, BC) has initiated commercialization of a new rapid detection test in its RAMP® line designed to detect strains of influenza A (flu A), including the Avian flu.
|
|
October 18 2005
Timely Challenge By Deborah Komlos Siegfried Hekimi, PhD embraced an opportune set of circumstances to establish Chronogen
|
|
September 20 2005
ProMetic a Finalist in Deloitte Fast 50 Program Montreal, Que.-based biopharmaceutical firm ProMetic Life Sciences Inc. has been named a finalist in Deloitte Fast 50 program, which recognizes the 50 fastest growing Canadian companies over a five-year period.
|
|
September 13 2005
Artisan of Change By Amber Lepage-Monette President and CEO Gilles Gagnon directs Aeterna Zentaris in its latest incarnation
|
|
July 05 2005
Allon Director Resigns Isaac Kohlberg, a founding director at Vancouver, B.C.-based Allon Therapeutics Inc., has resigned from the firm's board of directors.
|
|
June 20 2005
Viventia Establishes New Clinical Advisory Board Toronto, Ont.-based Viventia Biotech Inc. has announced the creation of its Head and Neck Cancer Clinical Advisory Board, designed to help the company develop late-stage clinical trials for its lead product, Proxinium(tm).
|
|
June 13 2005
ONTARIO - The Gateway to Success by Kristine Archer Ontario is poised to become a major global player in the biotech sector
|
|
May 17 2005
Biogen Idec Expands Mississauga Facility Biogen Idec Canada Inc., a subsidiary of Cambridge, Mass.-based biotechnology company Biogen Idec Inc., recently celebrated the expansion of its Mississauaga, Ont. offices.
|
|
May 10 2005
Intrinsic Drive By Deborah Komlos Lorus's Jim A. Wright, PhD has translated his passion for research into tangible therapeutic and corporate results
|
|
May 10 2005
United Front By Amber Lepage-Monette A proposed health research council could bring Ontario more funding, and unify a diverse community.
|
|
May 03 2005
Stressgen Announces Corporate Restructuring Victoria, B.C.-based Stressgen Biotechnologies Corp. has announced plans for a corporate restructuring designed to allow the company to focus solely on its lead drug candidate for human papillomavirus-related disease, HspE7.
|
|
April 19 2005
Millenia Hope Launches Asian Subsidiary Westmount, Que.-based Millenia Hope Inc. has announced plans to open a wholly owned subsidiary in Hong Kong.
|
|
April 12 2005
Natural Leader By Kristine Archer Jacqueline Shan, PhD discusses her successful journey with CV Technologies Inc.
|
|
April 12 2005
Provincial Power By Amber Lepage-Monette Health research organizations better position researchers for success
|
|
April 12 2005
EXCLUSIVE SPOTLIGHT: Ontario's New Biotech Voice By Deborah Komlos The BCO aims to be the public policy catalyst for growth
|
|
March 07 2005
Lifetime of Leadership By Amber Lepage-Monette Dr. Henry Friesen Discusses His Past and the Future of Canadian Health Care
|
|
February 28 2005
PricewaterhouseCoopers Creates New Pharma R&D Practice PricewaterhouseCoopers LLP (New York, NY) has announced the establishment of a new specialized pharmaceutical R&D operations practice.
|
|
January 13 2005
Top 10 Hits BioNorth's 11th By Tim Lougheed Everyone loves a top 10 list, and participants in Canada's international biotechnology and life sciences conference and exhibition are no exception. BioNorth is now in its 11th year, and for many people one of the highlights is the annual finalist list of Canadas Top 10 Life Science Companies, which was introduced in 1999.
|